| Luz Charielle Quezada Mejia, APN | |
|
254 Easton Ave, New Brunswick, NJ 08901-1766 | |
| (732) 745-8600 | |
| (732) 448-9741 |
| Full Name | Luz Charielle Quezada Mejia |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 254 Easton Ave, New Brunswick, New Jersey |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902402985 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 26NR15404200 (New Jersey) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | 26NJ01086600 (New Jersey) | Primary |
| Entity Name | Saint Peters University Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114924834 PECOS PAC ID: 9931012382 Enrollment ID: O20040112000043 |
News Archive
MiMedx Group, Inc., the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic, and the Dental sectors of healthcare, announced today its record revenue results for the third quarter of 2015, its guidance for the fourth quarter of 2015, and that the Company has secured a $50 million Senior Secured Credit Facility.
A large genomic analysis has linked certain DNA mutations to a high risk of relapse in estrogen receptor positive breast cancer, while other mutations were associated with better outcomes, according to researchers from Washington University School of Medicine in St. Louis, the Baylor College of Medicine and the University of British Columbia.
Swedish Neuroscience Institute (SNI) will open its new MS Center at Swedish to patients on April 9. Carefully designed for easy accessibility and to promote the well-being of people with Multiple Sclerosis (MS), the new 11,700-square-foot center gives SNI the ability to consolidate all of its MS services into one facility.
Every day nearly 200 people die from an overdose of drugs or from alcohol poisoning, with opioids responsible for the majority.
Imagine the benefits if there was technology that pinpointed exactly which chemotherapy drugs work best in fighting each individual's type of cancer. No more guessing. No more trial and error. The good news is that such lifesaving technology is on its way to becoming reality.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Luz Charielle Quezada Mejia, APN 254 Easton Ave, New Brunswick, NJ 08901-1766 Ph: (732) 745-8600 | Luz Charielle Quezada Mejia, APN 254 Easton Ave, New Brunswick, NJ 08901-1766 Ph: (732) 745-8600 |
News Archive
MiMedx Group, Inc., the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic, and the Dental sectors of healthcare, announced today its record revenue results for the third quarter of 2015, its guidance for the fourth quarter of 2015, and that the Company has secured a $50 million Senior Secured Credit Facility.
A large genomic analysis has linked certain DNA mutations to a high risk of relapse in estrogen receptor positive breast cancer, while other mutations were associated with better outcomes, according to researchers from Washington University School of Medicine in St. Louis, the Baylor College of Medicine and the University of British Columbia.
Swedish Neuroscience Institute (SNI) will open its new MS Center at Swedish to patients on April 9. Carefully designed for easy accessibility and to promote the well-being of people with Multiple Sclerosis (MS), the new 11,700-square-foot center gives SNI the ability to consolidate all of its MS services into one facility.
Every day nearly 200 people die from an overdose of drugs or from alcohol poisoning, with opioids responsible for the majority.
Imagine the benefits if there was technology that pinpointed exactly which chemotherapy drugs work best in fighting each individual's type of cancer. No more guessing. No more trial and error. The good news is that such lifesaving technology is on its way to becoming reality.
› Verified 7 days ago
Mrs. Courtney Elizabeth Resciniti, CRNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 125 Paterson St Ste 3300, New Brunswick, NJ 08901 Phone: 732-235-7821 Fax: 732-235-8878 | |
Lauren Horton, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 200 Somerset St, New Brunswick, NJ 08901 Phone: 888-244-5373 | |
Devon Amanda Orzano, APN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1 Robert Wood Johnson Pl, 2 Core - Rm. 257, New Brunswick, NJ 08901 Phone: 732-828-3000 | |
Sherene Tanasha Dunkley, APN-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 254 Easton Ave, New Brunswick, NJ 08901 Phone: 732-745-8600 | |
Andrew Thomas, MSN, APN-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1 Robert Wood Johnson Pl, New Brunswick, NJ 08901 Phone: 732-828-3000 | |
Daniela Manole Raabe, APN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 200 Somerset St, New Brunswick, NJ 08901 Phone: 646-226-2137 | |
Ms. Kathy O Covert, APN-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 254 Easton Ave, New Brunswick, NJ 08901 Phone: 732-745-8600 |